Literature DB >> 17708997

Nuclear inclusions in Huntington's disease.

S W Davies, E Scherzinger.   

Abstract

Entities:  

Year:  1997        PMID： 17708997     DOI： 10.1016/S0962-8924(97)88136-6

Source DB:  PubMed          Journal:  Trends Cell Biol        ISSN： 0962-8924            Impact factor:   20.808


× No keyword cloud information.
  11 in total

Review 1.  Differential vulnerability of neurons in Huntington's disease: the role of cell type-specific features.

Authors:  Ina Han; YiMei You; Jeffrey H Kordower; Scott T Brady; Gerardo A Morfini
Journal:  J Neurochem       Date:  2010-03-17       Impact factor: 5.372

2.  Differential degradation of full-length and cleaved ataxin-7 fragments in a novel stable inducible SCA7 model.

Authors:  Xin Yu; Abiodun Ajayi; Narasimha Rao Boga; Anna-Lena Ström
Journal:  J Mol Neurosci       Date:  2012-02-25       Impact factor: 3.444

Review 3.  Protein aggregates in Huntington's disease.

Authors:  Montserrat Arrasate; Steven Finkbeiner
Journal:  Exp Neurol       Date:  2011-12-19       Impact factor: 5.330

4.  Enhanced mitochondrial biogenesis ameliorates disease phenotype in a full-length mouse model of Huntington's disease.

Authors:  Abhishek Chandra; Abhijeet Sharma; Noel Y Calingasan; Joshua M White; Yevgeniya Shurubor; X William Yang; M Flint Beal; Ashu Johri
Journal:  Hum Mol Genet       Date:  2016-03-22       Impact factor: 6.150

5.  Expanded ataxin-7 cause toxicity by inducing ROS production from NADPH oxidase complexes in a stable inducible Spinocerebellar ataxia type 7 (SCA7) model.

Authors:  Abiodun Ajayi; Xin Yu; Staffan Lindberg; Ulo Langel; Anna-Lena Ström
Journal:  BMC Neurosci       Date:  2012-07-24       Impact factor: 3.288

6.  A High-Throughput Small Molecule Screen for C. elegans Linker Cell Death Inhibitors.

Authors:  Andrew R Schwendeman; Shai Shaham
Journal:  PLoS One       Date:  2016-10-07       Impact factor: 3.240

7.  Selective Sparing of Striatal Interneurons after Poly (ADP-Ribose) Polymerase 1 Inhibition in the R6/2 Mouse Model of Huntington's Disease.

Authors:  Emanuela Paldino; Antonella Cardinale; Vincenza D'Angelo; Ilaria Sauve; Carmela Giampà; Francesca R Fusco
Journal:  Front Neuroanat       Date:  2017-08-02       Impact factor: 3.856

8.  The longevity-associated variant of BPIFB4 improves a CXCR4-mediated striatum-microglia crosstalk preventing disease progression in a mouse model of Huntington's disease.

Authors:  Alba Di Pardo; Elena Ciaglia; Monica Cattaneo; Anna Maciag; Francesco Montella; Valentina Lopardo; Anna Ferrario; Francesco Villa; Michele Madonna; Enrico Amico; Albino Carrizzo; Antonio Damato; Giuseppe Pepe; Federico Marracino; Alberto Auricchio; Carmine Vecchione; Vittorio Maglione; Annibale A Puca
Journal:  Cell Death Dis       Date:  2020-07-18       Impact factor: 8.469

9.  Transgenic minipig model of Huntington's disease exhibiting gradually progressing neurodegeneration.

Authors:  Taras Ardan; Monika Baxa; Božena Levinská; Miroslava Sedláčková; The Duong Nguyen; Jiří Klíma; Štefan Juhás; Jana Juhásová; Petra Šmatlíková; Petra Vochozková; Jan Motlík; Zdenka Ellederová
Journal:  Dis Model Mech       Date:  2019-12-12       Impact factor: 5.758

10.  A novel and accurate full-length HTT mouse model for Huntington's disease.

Authors:  Sushila A Shenoy; Sushuang Zheng; Wencheng Liu; Yuanyi Dai; Yuanxiu Liu; Zhipeng Hou; Susumu Mori; Yi Tang; Jerry Cheng; Wenzhen Duan; Chenjian Li
Journal:  Elife       Date:  2022-01-13       Impact factor: 8.140
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.